exciting times. definitely coming into a "make or break" year for RCE. With capital starting to dry up it's never been more important
for the company to deliver some value in R327 in the form of clinical results. I really hope UTI is the catalyst we need to drive the share price higher. I'm not going to hold my breath but I am hopeful. I really thought burns would be the price driver but that never really eventuated. at least with CMAX we should have some definitive results by 3Q2023
Ann: Recce Selects CMAX for Phase I/II UTI Clinical Trial, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.080(21.9%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 44.5¢ | 37.5¢ | $191.2K | 477.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12222 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 10976 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |